The Middle EAST Bacteriophage Market was valued at USD 0.15 billion in 2024 and is projected to reach USD 0.45 billion by 2034, registering a CAGR of 12.0%. This growth trajectory is underpinned by increasing awareness of antibiotic resistance and the potential of bacteriophages as an alternative treatment option. The rising prevalence of bacterial infections, coupled with a growing acceptance...